Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V S Varma

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Pharmacological Research|August 7, 2003
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancementManthena V S Varma, Yasvanth Ashokraj, Chinmoy S Dey, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 12, 2021
Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in NigeriaOgochukwu Amaeze, Heather Eng, Lauren Horlbogen, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 26, 2005
In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studiesPradeep Sharma, Manthena V S Varma, Harmander P S Chawla, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 27, 2005
Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancersPradeep Sharma, Manthena V S Varma, Harmander P S Chawla, et al.
Journal of Medicinal Chemistry|October 21, 2022
Identification of Organic Anion Transporter 2 Inhibitors: Screening, Structure-Based Analysis, and Clinical Drug Interaction Risk AssessmentSangwoo Ryu, Nathaniel Woody, George Chang, et al.
The AAPS Journal|April 8, 2026
Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK AnalysisRui Li, Samantha Jordan, Mark Niosi, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 18, 2005
Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancersPradeep Sharma, Manthena V S Varma, Harmander P S Chawla, et al.
Journal of Pharmaceutical Sciences|September 26, 2009
The intestinal absorption of a prodrug of the mGlu2/3 receptor agonist LY354740 is mediated by PEPT1: in situ rat intestinal perfusion studiesAndré H Eriksson, Manthena V S Varma, Everett J Perkins, et al.
Clinical Pharmacokinetics|August 19, 2024
Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling FactorsRui Li, Emi Kimoto, Yi-An Bi, et al.
Molecular Pharmaceutics|September 18, 2015
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-GlucuronideEmi Kimoto, Rui Li, Renato J Scialis, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Pharmacological Research|August 7, 2003
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancementManthena V S Varma, Yasvanth Ashokraj, Chinmoy S Dey, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 12, 2021
Cytochrome P450 Enzyme Inhibition and Herb-Drug Interaction Potential of Medicinal Plant Extracts Used for Management of Diabetes in NigeriaOgochukwu Amaeze, Heather Eng, Lauren Horlbogen, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 26, 2005
In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studiesPradeep Sharma, Manthena V S Varma, Harmander P S Chawla, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 27, 2005
Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancersPradeep Sharma, Manthena V S Varma, Harmander P S Chawla, et al.
Journal of Medicinal Chemistry|October 21, 2022
Identification of Organic Anion Transporter 2 Inhibitors: Screening, Structure-Based Analysis, and Clinical Drug Interaction Risk AssessmentSangwoo Ryu, Nathaniel Woody, George Chang, et al.
The AAPS Journal|April 8, 2026
Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK AnalysisRui Li, Samantha Jordan, Mark Niosi, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 18, 2005
Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancersPradeep Sharma, Manthena V S Varma, Harmander P S Chawla, et al.
Journal of Pharmaceutical Sciences|September 26, 2009
The intestinal absorption of a prodrug of the mGlu2/3 receptor agonist LY354740 is mediated by PEPT1: in situ rat intestinal perfusion studiesAndré H Eriksson, Manthena V S Varma, Everett J Perkins, et al.
Clinical Pharmacokinetics|August 19, 2024
Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling FactorsRui Li, Emi Kimoto, Yi-An Bi, et al.
Molecular Pharmaceutics|September 18, 2015
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-GlucuronideEmi Kimoto, Rui Li, Renato J Scialis, et al.
Pageof 10